{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:36:23Z","timestamp":1790487383221,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:00:00Z","timestamp":1481673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/mi.2016.112","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T08:23:40Z","timestamp":1481703820000},"page":"924-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88"],"prefix":"10.1016","volume":"10","author":[{"given":"C.","family":"Benito-Villalvilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cirauqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Diez-Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Casanovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Subiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Palomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mi.2016.112_bib1","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2174\/1389450115666141020160705","article-title":"Extending the clinical horizons of mucosal bacterial vaccines: current evidence and future prospects","volume":"15","author":"Sanchez-Ramon","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1038\/mi.2016.112_bib2","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1038\/mi.2016.112_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijantimicag.2011.09.009","article-title":"Critical review of current definitions of urinary tract infections and proposal of an EAU\/ESIU classification system","volume":"38","author":"Johansen","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1038\/mi.2016.112_bib4","first-page":"39","article-title":"Managing recurrent urinary tract infections in women","volume":"1","author":"Nicolle","year":"2005","journal-title":"Womens Health"},{"key":"10.1038\/mi.2016.112_bib5","doi-asserted-by":"crossref","first-page":"236ed210","DOI":"10.1126\/scitranslmed.3009315","article-title":"Antimicrobial resistance: a global challenge","volume":"6","author":"Howard","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1038\/mi.2016.112_bib6","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/509S6a","article-title":"Microbiology: resistance fighters","volume":"509","author":"Cannon","year":"2014","journal-title":"Nature"},{"key":"10.1038\/mi.2016.112_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/509141a","article-title":"Antibiotic resistance sweeping developing world","volume":"509","author":"Reardon","year":"2014","journal-title":"Nature"},{"key":"10.1038\/mi.2016.112_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.eururo.2004.12.009","article-title":"A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections","volume":"47","author":"Bauer","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1038\/mi.2016.112_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2008.08.011","article-title":"Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis","volume":"33","author":"Naber","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1038\/mi.2016.112_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1574-695X.2000.tb01444.x","article-title":"Modulation of immune responses following antigen administration by mucosal route","volume":"27","author":"Medina","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1038\/mi.2016.112_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00192-012-1853-5","article-title":"Evaluation of a therapeutic vaccine for the prevention of recurrent urinary tract infections versus prophylactic treatment with antibiotics","volume":"24","author":"Lorenzo-Gomez","year":"2013","journal-title":"Int. Urogynecol. J."},{"key":"10.1038\/mi.2016.112_bib12","first-page":"50","article-title":"Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections","volume":"5","author":"Lorenzo-Gomez","year":"2015","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1038\/mi.2016.112_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/hv.7.1.13739","article-title":"Sublingual vaccination","volume":"7","author":"Czerkinsky","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1038\/mi.2016.112_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaip.2013.03.013","article-title":"Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician","volume":"1","author":"Moingeon","year":"2013","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1038\/mi.2016.112_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/mi.2008.57","article-title":"Dendritic cells and macrophages in the genitourinary tract","volume":"1","author":"Iijima","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2016.112_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2015.00129","article-title":"The known unknowns of the human dendritic cell network","volume":"6","author":"Durand","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1038\/mi.2016.112_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2014.12.011","article-title":"Microbial strategies for antagonizing Toll-like-receptor signal transduction","volume":"32","author":"Rosadini","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1038\/mi.2016.112_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.imbio.2014.09.013","article-title":"Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors","volume":"220","author":"Iborra","year":"2015","journal-title":"Immunobiology"},{"key":"10.1038\/mi.2016.112_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1038\/mi.2016.112_bib20","unstructured":"WHO Antimicrobial resistance: global report on surveillance (2014) Available from http:\/\/www.who.int."},{"key":"10.1038\/mi.2016.112_bib21","unstructured":"World-Economic-Forum Global Risks 2014, Ninth Edn. (2014) Available from www.weforum.org\/risks."},{"key":"10.1038\/mi.2016.112_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/cr100407j","article-title":"Introduction to bacterial signals and chemical communication","volume":"111","author":"Blackwell","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1038\/mi.2016.112_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri3167","article-title":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat","volume":"12","author":"Blander","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/mi.2016.112_bib24","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1038\/mi.2016.112_bib25","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2010.04.013","article-title":"Persistence of mucosal and systemic immune responses following sublingual immunization","volume":"28","author":"Negri","year":"2010","journal-title":"Vaccine"},{"key":"10.1038\/mi.2016.112_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"10.1038\/mi.2016.112_bib27","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jaci.2011.04.002","article-title":"The many routes of dendritic cells to ensure immune regulation","volume":"127","author":"Palomares","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/mi.2016.112_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaci.2011.09.031","article-title":"Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance","volume":"129","author":"Palomares","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/mi.2016.112_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/gene.2014.45","article-title":"Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta","volume":"15","author":"Palomares","year":"2014","journal-title":"Genes Immun."},{"key":"10.1038\/mi.2016.112_bib30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/mi.2014.17","article-title":"Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium","volume":"7","author":"Wang","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2016.112_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fimmu.2015.00527","article-title":"Immunity to pathogens taught by specialized human dendritic cell subsets","volume":"6","author":"Geginat","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1038\/mi.2016.112_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/mi.2014.64","article-title":"Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells","volume":"8","author":"Bakdash","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2016.112_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14452","article-title":"Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature"},{"key":"10.1038\/mi.2016.112_bib34","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jaci.2012.05.003","article-title":"TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection","volume":"129","author":"Akdis","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/mi.2016.112_bib35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/mi.2016.19","article-title":"Regulatory T cells are essential to promote proper CD4 T-cell priming upon mucosal infection","volume":"9","author":"Soerens","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2016.112_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/mi.2012.117","article-title":"Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates","volume":"6","author":"Warfel","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1038\/mi.2016.112_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coi.2012.12.007","article-title":"Sensing of cell death by myeloid C-type lectin receptors","volume":"25","author":"Sancho","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1038\/mi.2016.112_bib38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaci.2016.02.029","article-title":"Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1","volume":"138","author":"Sirvent","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/mi.2016.112_bib39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffel","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1038\/mi.2016.112_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbamcr.2014.10.022","article-title":"Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer","volume":"1853","author":"Krisenko","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1038\/mi.2016.112_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.it.2011.01.002","article-title":"Syk-coupled C-type lectins in immunity","volume":"32","author":"Kerrigan","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1038\/mi.2016.112_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2005.11.004","article-title":"Differential role of MAPK signaling in human dendritic cell maturation and Th1\/Th2 engagement","volume":"42","author":"Nakahara","year":"2006","journal-title":"J. Dermatol. Sci."},{"key":"10.1038\/mi.2016.112_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2217\/imt.10.99","article-title":"Small-molecule protein kinase inhibitors and their effects on the immune system: implications for cancer treatment","volume":"3","author":"Ott","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1038\/mi.2016.112_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.it.2008.03.005","article-title":"Turning NF-kappaB and IRFs on and off in DC","volume":"29","author":"Kaisho","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1038\/mi.2016.112_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cmi.2011.58","article-title":"C-type lectin receptor-induced NF-kappaB activation in innate immune and inflammatory responses","volume":"9","author":"Kingeter","year":"2012","journal-title":"Cell Mol. Immunol."},{"key":"10.1038\/mi.2016.112_bib46","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/eji.200636830","article-title":"Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan","volume":"37","author":"Slack","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1038\/mi.2016.112_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1189\/jlb.0804481","article-title":"Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways","volume":"78","author":"Lin","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1038\/mi.2016.112_bib48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/intimm\/dxh171","article-title":"Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells","volume":"16","author":"Nakahara","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1038\/mi.2016.112_bib49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fimmu.2014.00255","article-title":"Dendritic cell-targeted vaccines","volume":"5","author":"Cohn","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1038\/mi.2016.112_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mi2016112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mi2016112","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922007024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922007024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mi.2016.112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/mi2016112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:17:46Z","timestamp":1761830266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922007024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1933021922007024"],"URL":"https:\/\/doi.org\/10.1038\/mi.2016.112","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mi.2016.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 The authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}